Lenalidomide (LEN) maintenance (MNTC) after high-dose melphalan and autologous stem cell transplant (ASCT) in multiple myeloma (MM): A meta-analysis (MA) of overall survival (OS) CALGB 100104 (Alliance)
   Google Scholar   
Citation:
J. Clin. Oncol. vol 34 (suppl) abstr 8001
Meeting Instance:
ASCO 2016
Year:
2016
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Status:
Presented/Published
Citation Status:
epub
Note:
Corresponding Author: Philip L. McCarthy
Methodological:
No
Biospecimen:
No
DataSharing:
No
Parents:
None
Children:
2737  
Program:
OGC
Primary Committee:
Myeloma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA031946, U10CA033601, U10CA180821, U10CA180882  
Corr. Author:
 
Authors:
                             
Primary Study
CALGB-100104
Secondary Studies:
Phases:
3
Keywords: